These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 33356546)
41. Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin. Lampl Y; Lorberboym M; Gilad R; Vysberg I; Tikozky A; Sadeh M; Boaz M Clin Neuropharmacol; 2010 May; 33(3):129-34. PubMed ID: 20502132 [TBL] [Abstract][Full Text] [Related]
42. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Ballantyne CM; Olsson AG; Cook TJ; Mercuri MF; Pedersen TR; Kjekshus J Circulation; 2001 Dec; 104(25):3046-51. PubMed ID: 11748098 [TBL] [Abstract][Full Text] [Related]
43. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment. Frambach SJCM; de Haas R; Smeitink JAM; Rongen GA; Russel FGM; Schirris TJJ Pharmacol Rev; 2020 Jan; 72(1):152-190. PubMed ID: 31831519 [TBL] [Abstract][Full Text] [Related]
44. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin. Nestel P; Simons L; Barter P; Clifton P; Colquhoun D; Hamilton-Craig I; Sikaris K; Sullivan D Atherosclerosis; 1997 Mar; 129(2):231-9. PubMed ID: 9105566 [TBL] [Abstract][Full Text] [Related]
45. Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C. Miller M; Dobs A; Yuan Z; Battisti WP; Borisute H; Palmisano J Curr Med Res Opin; 2004 Jul; 20(7):1087-94. PubMed ID: 15265253 [TBL] [Abstract][Full Text] [Related]
46. No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin. Singhal MK; Bhaskaran S; Szabo T; La Rosa R Perit Dial Int; 1999; 19(1):89-91. PubMed ID: 10201354 [No Abstract] [Full Text] [Related]
47. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study). Robinson JG; Ballantyne CM; Grundy SM; Hsueh WA; Parving HH; Rosen JB; Adewale AJ; Polis AB; Tomassini JE; Tershakovec AM Am J Cardiol; 2009 Jun; 103(12):1694-702. PubMed ID: 19539078 [TBL] [Abstract][Full Text] [Related]
48. A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin. Rogers SL; Magliano DJ; Levison DB; Webb K; Clarke PJ; Grobler MP; Liew D Clin Ther; 2007 Feb; 29(2):242-52. PubMed ID: 17472817 [TBL] [Abstract][Full Text] [Related]
49. Lipid lowering activity of Citri unshii pericarpium in hyperlipemic rats. Yang G; Lee J; Jung ED; Ham I; Choi HY Immunopharmacol Immunotoxicol; 2008; 30(4):783-91. PubMed ID: 18686099 [TBL] [Abstract][Full Text] [Related]
50. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia. Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197 [TBL] [Abstract][Full Text] [Related]
51. Effect of simvastatin on the lipid profile of hemodialysis patients. Nishikawa O; Mune M; Miyano M; Nishide T; Nishide I; Maeda A; Kimura K; Takahashi T; Kishino M; Tone Y; Otani H; Ogawa A; Maeda T; Yukawa S Kidney Int Suppl; 1999 Jul; 71():S219-21. PubMed ID: 10412781 [TBL] [Abstract][Full Text] [Related]
52. Use of simvastatin treatment in patients with combined hyperlipidemia in clinical practice. For the Simvastatin Combined Hyperlipidemia Registry Group. Vicari RM; Wan GJ; Aura AM; Alexander CM; Markson LE; Teutsch SM Arch Fam Med; 2000; 9(9):898-905. PubMed ID: 11031398 [TBL] [Abstract][Full Text] [Related]
53. Overall and sex-specific associations between methylation of the ABCG1 and APOE genes and ischemic stroke or other atherosclerosis-related traits in a sibling study of Chinese population. Qin X; Li J; Wu T; Wu Y; Tang X; Gao P; Li L; Wang M; Wu Y; Wang X; Chen D; Hu Y Clin Epigenetics; 2019 Dec; 11(1):189. PubMed ID: 31823830 [TBL] [Abstract][Full Text] [Related]
54. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia. Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370 [TBL] [Abstract][Full Text] [Related]
55. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial. Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB; Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446 [TBL] [Abstract][Full Text] [Related]
56. [Effects of policosanol combined with simvastatin on serum lipids and sex hormones in male patients with hyperlipidemia]. Tang M; Wu SZ; Gong X Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):488-92. PubMed ID: 24113041 [TBL] [Abstract][Full Text] [Related]
57. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. Davidson MH; McGarry T; Bettis R; Melani L; Lipka LJ; LeBeaut AP; Suresh R; Sun S; Veltri EP J Am Coll Cardiol; 2002 Dec; 40(12):2125-34. PubMed ID: 12505224 [TBL] [Abstract][Full Text] [Related]
58. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Gylling H; Miettinen TA Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225 [TBL] [Abstract][Full Text] [Related]
59. Lipid-lowering effects of ezetimibe and simvastatin in combination. Ijioma N; Robinson JG Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):131-45. PubMed ID: 21453210 [TBL] [Abstract][Full Text] [Related]
60. [Effects of HuDan Granules on lipid metabolism and antioxidant activity of mice with hyperlipidemia]. Zheng MW; Zheng L Zhong Yao Cai; 2008 Mar; 31(3):410-2. PubMed ID: 18619250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]